1. Achieving Controlled Nucleation During Aseptic Lyophilization

    Controlled nucleation is essential for obtaining high-quality lyophilized products with intra- and inter-batch consistency, says Robert Darrington, VP, Technical Marketing, SP Industries, Inc.

  2. Keys to Cultural Integration

    That’s Nice sat down with Catherine Hanley, Alcami’s Director of Marketing, to find out how to successfully integrate after a merger.

  3. Leveraging Hot Melt Extrusion for Solubility and Continuous Manufacturing

    Hot melt extrusion (HME) technology has become a key solution to adding absorption for enhanced solubility, says Tony Listro, Vice President, Technical Business Development at Foster Delivery Science.

  4. Becoming Bioavailable

    Poorly soluble molecules in the pipeline can have a negative effect on your active pharmaceutical ingredient (API).

  5. Making Real-Time Process Analytical Technology In Biomanufacturing A Reality
    Clint Pepper, Ph.D., Director of MAST Technology at Capsugel, explains the Modular Automated Sampling Technology platform.
  6. What are the Greatest Challenges Drug Manufacturers Face When Working to Meet the New Requirements for Excipient Supply Chain Security?

    Industry experts weigh in on our Roundtable question.

  7. AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax

    The US Food and Drug Administration (FDA) has granted venetoclax two Breakthrough Therapy Designations (BTDs) in AML, which are designed to expedite the development and review of medicines that are intended to treat a serious condition.

  8. New Treatment for Excessive Sweating Gets FDA Approval

    Demira’s awareness campaign for Qbrexa is drawing significant interest.

  9. Abbott Receives FDA Approval for Next-Generation MitraClip® Device to Treat People with Leaky Heart Valves

    The next-generation MitraClip system provides cardiologists with advanced steering, navigation, and positioning capabilities for the clip, making it easier to use in difficult anatomies. 

  10. Women’s Health Company to Expand

    Scottish company DYSUS Medical raises $25 million from Lundbeckfonden Ventures.


  11. Providing Flexible Capabilities to Meet Market Demand for Sterile Fill-Finish Services

    Andrea Baiocchi, Site Leader for Liscate at Avara Pharmaceutical Services discusses meeting the need for sterile fill-finish capabilities.

  12. Dissolving Boundaries in Worldwide Clinical Trial Logistics for Biological Samples and New Therapies

    Ariette van Strien, Chief Commercial Officer and Daniel Bell, Vice President, Regulatory Compliance & Technical Affairs at Marken, discuss clinical trial logistics without boundaries. 

  13. Scientific Expertise Facilitates Oral Peptide Product Development and Manufacturing

    Ariana Nagel, Director of Product Development, R&D and and Matthew Ferrell, Director of Analytical Development at UPM Pharmaceuticals explain the benefits and challenges of peptide therapies.

  14. Addressing Development Challenges for Complex Biologic Drug Candidates

    Karen Fallen, Vice President, Business Unit Head of Clinical Development & Manufacturing at Lonza, discusses how to handle increasingly complex biological candidates.

  15. Tackling Powder Flow Problems by Choosing the Right Equipment

    Identifying the source of product flow problems and correcting them with the right piece of equipment will result in more efficient and quality manufacturing, says Matt Hicks , Chief Operating Officer & Counsel for Federal Equipment Company.

  16. A Holistic Interpretation of Commitment to Quality
    Products manufactured by the Grifols Partnership CDMO are of vital importance to patient health and quality of life.
  17. Changes in the Biopharma Industry: from Minor to Major Evolution
    Real-world evidence and digital technologies are creating new medical solutions that will change the way diseases are detected, treated and prevented.
  18. Organ-on-a-Chip Company Raises $36 Million
    Technology is being developed as alternative to animal testing.
  19. Pfizer Announces it Will Defer Company’s Price Increases

    Following an extensive discussion with President Trump today, Pfizer’s Chairman and CEO Ian Read announced that it will defer the company’s price increases.

  20. MedImmune and 4D Molecular Therapeutics Collaborate to Design, Develop and Commercialize AAV Gene Therapy for Chronic Lung Disease

    MedImmune, the global biologics research and development arm of AstraZeneca, and 4D Molecular Therapeutics (4DMT), announced a collaboration to develop and commercialize a gene therapeutic for patients with chronic lung disease, utilizing 4DMT’s novel discovery platform to generate optimized AAV vectors.

View All

Road To BIO: Coming Soon To Your Screen Q4 2018
The Road to BIO in Review
The Road To BIO: Day 12 California
The Road To BIO: Day 11 Arizona /// California
The Road To BIO: Day 10 Texas /// Arizona
The Road To BIO: Day 9 Texas
The Road To BIO: Day 8 Texas
The Road To BIO: Day 7 Mississippi /// Texas
The Road To BIO: Day 6 Georgia /// Mississippi
The Road To BIO: Day 5 South Carolina /// Georgia
The Road To BIO: Day 4 Tennessee /// South Carolina
The Road To BIO: Day 3 Pennsylvania /// Tennessee
The Road To BIO: Day 2 New York /// Pennsylvania
For Your Listening Pleasure
The full story of this epic journey can be experienced as an audiobook. Listen to the story behind the story – the characters, the challenges, and all 12 days of the Road To BIO.
Nice Insight Awareness/Perception Scorecard

Research. Compare. Contact. Find the Ideal Partner.

Customer Awareness (CA) describes a buyer’s knowledge of your offering, while Customer Perception (CP) describes how a buyer rates your company based on that knowledge. Nice Insight’s CA/CP scorecard allows you to measure market awareness and perception of you and your industry peers based on acknowledged outsourcing drivers.

  1. Search by company type, region, market segment and services.
  2. Select up to 5 companies to compare.
  3. View CA & CP performance scores against industry benchmark ratings.

Digital Ad Spending by Pharma is Growing Slowly

Jul 13, 2018 11:40:21 AM PAO-M07-18-NI-008
FDA Approval

New Treatment for Excessive Sweating Gets FDA Approval

Jul 13, 2018 11:29:42 AM PAO-M07-18-NI-008

Women’s Health Company to Expand

Jul 13, 2018 11:25:25 AM PAO-M07-18-NI-007
Clinical Research

Eating Well Might Improve Cancer Treatments

Jul 12, 2018 2:59:14 PM PAO-M07-18-NI-006

Organ-on-a-Chip Company Raises $36 Million

Jul 12, 2018 2:54:35 PM PAO-M07-18-NI-005

Bosch Packaging Business Up for Sale

Jul 10, 2018 11:06:51 AM PAO-M07-18-NI-004

Gottlieb Discusses Results of Online Opioid Summit

Jul 10, 2018 11:04:07 AM PAO-M07-18-NI-003

Alcon Set Out On its Own

Jul 10, 2018 10:59:59 AM PAO-M07-18-NI-002

Japan Approves Two New AstraZeneca Cancer Meds

Jul 10, 2018 10:24:44 AM PAO-M07-18-NI-001

Nice Insight Overview

Changes in the  Biopharma Industry: from Minor to Major Evolution
New technologies such as gene editing are leading to the development of even more advanced, targeted medicines.

The Next-Generation Player

Addressing Development Challenges for Complex Biologic Drug Candidates
At Lonza, we are constantly looking to reduce the development timeline, giving our customers more control over their projects.

Karen Fallen, Vice President, Business Unit Head of Clinical Development & Manufacturing Lonza Pharma & Biotech

M+A Column

Inside Mergers & Acquisitions
Kevin Bottomley Partner, Results Healthcare
Deals in the pharmaceutical industry are an important mechanism of acquiring innovation, business and efficiency.

Nice Insight Overview

Doping: Famous Cases, Substances and Values in Sports

Marc Technow, Nice Insight